Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biovica International AB Class B (DE:9II)
FRANKFURT:9II
Holding DE:9II?
Track your performance easily
9II Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.10 - €0.26
Previous Close€0.13
Volume0.00
Average Volume (3M)N/A
Market Cap
€14.04M
Enterprise Value€2.45M
Total Cash (Recent Filing)kr145.15M
Total Debt (Recent Filing)kr11.09M
Price to Earnings (P/E)―
Beta-0.52
Next Earnings
Dec 12, 2024EPS Estimate
-€0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)169.70
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biovica International AB Class B News
9II FAQ
What was Biovica International AB Class B’s price range in the past 12 months?
Biovica International AB Class B lowest stock price was €0.10 and its highest was €0.26 in the past 12 months.
What is Biovica International AB Class B’s market cap?
Currently, no data Available
When is Biovica International AB Class B’s upcoming earnings report date?
Biovica International AB Class B’s upcoming earnings report date is Dec 12, 2024 which is in 20 days.
How were Biovica International AB Class B’s earnings last quarter?
Biovica International AB Class B released its earnings results on Sep 12, 2024. The company reported -€0.025 earnings per share for the quarter, missing the consensus estimate of -€0.019 by -€0.006.
Is Biovica International AB Class B overvalued?
According to Wall Street analysts Biovica International AB Class B’s price is currently Overvalued.
Does Biovica International AB Class B pay dividends?
Biovica International AB Class B does not currently pay dividends.
What is Biovica International AB Class B’s EPS estimate?
Biovica International AB Class B’s EPS estimate is -€0.02.
How many shares outstanding does Biovica International AB Class B have?
Biovica International AB Class B has 84,073,710 shares outstanding.
What happened to Biovica International AB Class B’s price movement after its last earnings report?
Biovica International AB Class B reported an EPS of -€0.025 in its last earnings report, missing expectations of -€0.019. Following the earnings report the stock price went down -5%.
Which hedge fund is a major shareholder of Biovica International AB Class B?
Currently, no hedge funds are holding shares in DE:9II
---
Biovica International AB Class B Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.02%
12-Months-Change
Fundamentals
Return on Equity
-119.05%
Trailing 12-Months
Asset Growth
-15.33%
Trailing 12-Months
Company Description
Biovica International AB Class B
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.
---
Technical Analysis
---